Endoscopic resection (ER) for early (pT1) esophageal adenocarcinoma can be justified if
the rate of coexisting lymph node (LN) metastasis is less than the mortality rate from …

Background: The modern therapy of early esophageal carcinomas (pT1) requires an
excellent cooperation between experienced gastroenterologists, pathologists, and …

BACKGROUND & AIMS: Patients with early-stage mucosal (T1a) esophageal
adenocarcinoma (EAC) are increasingly treated by endoscopic resection. EACs limited to …

Objective: The purpose of this review is to familiarize the reader with endoscopic resection
(ER) options for early-stage esophageal cancers. Background: Esophageal cancer consists …

Background Knowledge of factors related to outcome is vital for the selection of therapeutic
alternatives for patients with early (T1) esophageal adenocarcinoma. This study was …

High-risk T1 esophageal adenocarcinoma (HR-T1 EAC) is defined as T1 cancer, with one or
more of the following histological criteria: submucosal invasion, poorly or undifferentiated …

Whereas the incidence of squamous cell carcinoma of the esophagus is slightly decreasing,
adenocarcinoma shows a strong increase. Currently, the rate of pT1 tumors of both entities …

Objective: There has been an increase in interest in endoscopic therapy (ET) for
intramucosal (T1a) or submucosal (T1b) esophageal carcinoma. The objective of the …

Objective: The aim of this study was to evaluate the outcome of endoscopic resection (ER)
versus esophagectomy in node-negative cT1a and cT1b esophageal adenocarcinoma …

Patients with early (T1) esophageal adenocarcinoma (EAC) are increasingly having
definitive local therapy endoscopically. Endoscopic resection is not able to pathologically …